June 22, 2026 TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation
June 22, 2026 GRAL Alert: GRAIL, Inc. Investors may have been Misled about the Company’s Trial Results – Contact BFA Law about the Pending Securities Fraud Class Action
June 22, 2026 MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
